Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Organisation › Details

Metagenomi Inc.

At Metagenomi, we are accelerating innovation in cell and gene therapy with a wave of proprietary CRISPR-based systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. We adapt and forge these naturally evolved systems into powerful therapeutic tools that can be leveraged by partners and fuel our own pipeline of potentially curative medicines. Our goal is to revolutionize gene editing and unlock its power for the benefit of patients around the world. *


Period Start 2018-01-01 established (s-off
  Predecessor University of California, Berkeley
Products Industry CRISPR gene editing technology
  Industry 2 genomics
Persons Person Thomas, Brian C. (Metagenomi 202011 CEO + Co-Founder)
  Person 2 Knowles, Jak (Metagenomi 202011– CBO before Leaps by Bayer)
Region Region Emeryville, CA
  Country United States (USA)
  Street 5980 Horton Street
Suite 600
  City 94608 Emeryville, CA
    Address record changed: 2021-01-18
Basic data Employees n. a.
    * Document for �About Section�: Bayer AG. (11/12/20). "Press Release: Metagenomi Closes USD 65 Million Series A Financing Led by Leaps by Bayer and Humboldt Fund". Emeryville, CA & Leverkusen.
Record changed: 2020-11-30


Picture [iito] Plain Stupid Simple 650x80px

More documents for Metagenomi Inc.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Made Without Love 650x80px

» top